OxStem Neuro, co-founded with Prof. Francis Szele was launched on 3rd August.
OxStem Neuro aims to identify drugs that will stimulate de novo neuron production from neural stem cells that will compensate for disease pathology in neurodegenerative diseases, stroke and traumatic brain injury. It is a subsidiary of OxStem, an Oxford spin-out co-founded by Prof. Angela Russell, Prof. Steve Davies (Chemistry) and Dame Prof.Kay Davies.
Three Postdoctoral Fellows and a Research Assistant will be recruited. It will be funded within the University over the next three years following OxStem’s record £16.9M initial fundraise in May 2016. This new project builds on a three year collaborative project between the Szele/Russell/S. Davies labs that has identified several compounds that increase neurogenesis in vitro. Click here for further information.